European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer

Background We identify socioeconomic disparities by region in cancer morbidity and mortality in England for all-cancer and type-specific cancers, and use incidence data to quantify the impact of cancer diagnosis delays on cancer deaths between 2001–2016. Methods and findings We obtain population cancer morbidity and mortality rates at various age, year, gender, deprivation, and region levels based on a Bayesian approach. A significant increase in type-specific cancer deaths, which can also vary among regions, is shown as a result of delay in cancer diagnoses. Our analysis suggests increase of 7.75% (7.42% to 8.25%) in female lung cancer mortality in London, as an impact of 12-month delay in cancer diagnosis, and a 3.39% (3.29% to 3.48%) increase in male lung cancer mortality across all regions. The same delay can cause a 23.56% (23.09% to 24.30%) increase in male bowel cancer mortality. Furthermore, for all-cancer mortality, the highest increase in deprivation gap happened in the East Midlands, from 199 (186 to 212) in 2001, to 239 (224 to 252) in 2016 for males, and from 114 (107 to 121) to 163 (155 to 171) for females. Also, for female lung cancer, the deprivation gap has widened with the highest change in the North West, e.g. for incidence from 180 (172 to 188) to 272 (261 to 282), whereas it has narrowed for prostate cancer incidence with the biggest reduction in the South West from 165 (139 to 190) in 2001 to 95 (72 to 117) in 2016. Conclusions The analysis reveals considerable disparities in all-cancer and some type-specific cancers with respect to socioeconomic status. Furthermore, a significant increase in cancer deaths is shown as a result of delays in cancer diagnoses which can be linked to concerns about the effect of delay in cancer screening and diagnosis during the COVID-19 pandemic. Public health interventions at regional and deprivation level can contribute to prevention of cancer deaths.

Download Full-text

ASSOCIATIONS BETWEEN FEMALE LUNG CANCER MORTALITY AND NO, NOX, AND NO2 IN KAOHSIUNG, TAIWAN

ISEE Conference Abstracts ◽

10.1289/isee.2011.01127 ◽

2011 ◽

Vol 2011 (1) ◽

Author(s):

Shu-Yuan Chen ◽

Chieh-Wen Chen ◽

Yao-Chin Wang ◽

Jen-Feng Yeh ◽

Tzu-Chi Chiu

Keyword(s):

Lung Cancer ◽

Cancer Mortality ◽

Lung Cancer Mortality ◽

Female Lung Cancer

Download Full-text

Geographical Disparities of Lung Cancer Mortality Centered on Central Appalachia

International Journal of Applied Geospatial Research ◽

10.4018/ijagr.2014100103 ◽

2014 ◽

Vol 5 (4) ◽

pp. 35-53

Author(s):

Timothy S. Hare ◽

Chad Wells ◽

Nicole Johnson

Keyword(s):

Lung Cancer ◽

Cancer Mortality ◽

Spatial Clustering ◽

Lung Cancer Mortality ◽

Mortality Rates ◽

Factors Associated ◽

Level Data ◽

Central Appalachia ◽

Specific Factors ◽

Female Lung Cancer

This article explores regional disparities in lung cancer mortality for females and males and associated factors across central Appalachia and surrounding regions. It asks, how are lung cancer mortality rates distributed geographically, what are the relative contributions of specific factors to lung cancer disparities by sex, and how do the effects of these factors vary across the study area? This study is based on county-level data of potential determinants of disease to explore local effects on lung cancer mortality. It analyzes these data using a combination of spatial statistical analyses. The analysis shows that the spatial clustering of high lung cancer mortality rates differs for females and males. Additionally, the factors associated with lung cancer for females and males differ greatly. For instance, tobacco use is associated with male lung cancer mortality, but not with female lung cancer mortality. These factors also vary in their geographical relationships with female and male lung cancer mortality.

Download Full-text

Cancer Mortality in Italy, 1993

Tumori Journal ◽

10.1177/030089169708300303 ◽

1997 ◽

Vol 83 (3) ◽

pp. 643-649 ◽

Cited By ~ 8

Author(s):

Adriano Decarli ◽

Carlo La Vecchia

Keyword(s):

Lung Cancer ◽

Cancer Mortality ◽

Mortality Rates ◽

Death Certification ◽

Appreciable Change ◽

Standard Population ◽

Younger Age ◽

World Standard ◽

Cancer Rates ◽

Female Lung Cancer

Background Data and statistics are presented on cancer death certification for 1993 in Italy, updating previous publications covering the period 1955–1992. Methods Data for 1993 subdivided into 30 cancer sites are presented in 8 tables, including age-and sex-specific absolute and percentage frequencies of cancer deaths, and crude, age-specific and age-standardized rates, at all ages and truncated for the 35–64 year age group. Results Age-adjusted death certification rates (on the world standard population) for all neoplasms declined from 189.8 in 1992 (and a peak of 199.2 in 1986) to 187.8/100, 000 males in 1993, and remained stable around 100, 000 females. The favorable trends were even larger in middle and younger age males, but not in children below age 15, whose overall age-standardized cancer mortality rates increased for the fourth subsequent year. Lung cancer was the leading site of cancer mortality, with over 30, 900 deaths. For the fifth subsequent year, its rates in males declined, to reach 56.0/100,000. The decline in lung cancer rates is now established in Italian males and is substantial in middle age, whereas the rise in female lung cancer rates seems to have leveled off over the last few years. Rates for other major cancer sites (intestines, stomach, female breast, prostate, pancreas, leukemias and lymphomas) were stable, but some decrease was apparent also in 1993 for Hodgkin's disease. Conclusions Italian cancer mortality rates in 1993 were moderately favorable in males, due to the leveling of the tobacco-related epidemic, whereas no appreciable change was registered in females. The persisting unfavorable trends in childhood cancer mortality should be investigated.

Download Full-text